STAT News

STAT+: Biotech’s rebound isn’t lifting all boats equally

Biotech is having a good year, though you wouldn't necessarily know it from how investors are treating positive clinical data.

By STAT News

1 min read
STAT+: Biotech’s rebound isn’t lifting all boats equally
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights